Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

150 evidences · page 1 / 6

36 %36% of women attending large HIV care and treatment programs across Kenya between June and September 2016 knew cervical cancer is treatable.

Kenyacancer du col de l'utérusobservé June and September 2016publié 2022International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument de 3 observations

24,5 %Twenty-four point five percent (23/94) of the respondents who had ever been screened perceived cervical screening procedures as embarrassing.

Kenyacancer du col de l'utéruspublié 2016Journals & Books Hosting (International Knowledge Sharing Platform)OpenAlexdocument de 18 observations

71 %Only 71% (27) of clinics that reported performing cervical cancer screening had dependable access to acetic acid.

Kenyacancer du col de l'utérusobservé 2017-2018publié 2022BMC health services researcheurope_pmcdocument de 10 observationsDOI 10.1186/s12913-022-08984-2

44,5 %The average relative survival from cervical cancer in the 11 countries was 44.5% at 3 years.

Kenyacancer du col de l'utérusobservé 2005 to 2015publié 2020International journal of cancereurope_pmcdocument de 6 observations

3,88 hazard_rate_ratioIn patients with cervical cancer, cancer-directed therapy without curative potential was associated with worse overall survival (hazard rate ratio, 3.88; 95% confidence interval, 1.19–12.71).

Kenyacancer du col de l'utéruspublié 2021The oncologisteurope_pmcdocument de 14 observationsDOI 10.1002/onco.13718

4 %The smallest share of guideline-adherent cancer-directed therapy was observed in Maputo (4%).

Kenyacancer du col de l'utéruspublié 2021The oncologisteurope_pmcdocument de 14 observationsDOI 10.1002/onco.13718

247 womenUse of the mobile phone-based app is projected to detect and treat an additional 247 women — 229 with precancerous cervical lesions and 18 with cervical cancer — in a simulated cohort of 10,000 women per arm.

Kenyacancer du col de l'utérus · precancerous cervical lesionspublié 2025PloS onePubMeddocument de 3 observations

54 %Fifty-four percent (38/70) of clinic managers reported that their clinics performed cervical cancer screening.

Kenyacancer du col de l'utérusobservé 2017-2018publié 2022BMC health services researcheurope_pmcdocument de 10 observationsDOI 10.1186/s12913-022-08984-2

21 990 casesA total of 21,990 cases of cervical cancer were included in the analyses.

Kenyacancer du col de l'utéruspublié 2020British journal of cancereurope_pmcdocument de 5 observations

45,9 per_100_person_yearsOf the 162 women in the study, 70 (43.2%) died giving an overall incidence rate of 45.9 deaths per 100 person years of follow up.

Kenyacancer du col de l'utéruspublié 2023BMC cancerPubMeddocument de 12 observations

70 %In Kenya, up to 70% of screen-positive women do not receive treatment.

Kenyacancer du col de l'utéruspublié 2023Implementation science : ISPubMeddocument de 2 observations

340 000 deathsGlobally, there were over 340,000 cervical cancer deaths in 2020.

Kenyacancer du col de l'utérusobservé 2020publié 2023PloS onePubMeddocument de 16 observations

77,6 %The 3-year disease-free survival was 77.6% among HIV-negative patients.

Kenyacancer du col de l'utérusobservé 2014–2023publié 2026BMC cancerPubMeddocument de 16 observations

Cervical cancer is currently ranked the highest cause of cancer deaths in Kenya.

Kenyacancer du col de l'utéruspublié 2016Journals & Books Hosting (International Knowledge Sharing Platform)OpenAlexdocument de 18 observations

In Kenya, cervical cancer is the leading cause of cancer-related mortality among women of reproductive age.

Kenyacancer du col de l'utéruspublié 2014BMC public healtheurope_pmcdocument de 2 observations

2,12 odds_ratioYoung women who did not know where to obtain condoms had an odds ratio of 2.12 for being unaware of cervical cancer.

Kenyacancer du col de l'utéruspublié 2020PloS onePubMeddocument de 5 observations

1 per_317Among 317 women, invasive cervical cancer cases included HPV16 in 1/317 (0.3%) and HPV81 in 3/317 (0.9%).

Kenyacancer du col de l'utéruspublié 2021BioMed research internationalPubMeddocument de 9 observations

60,9 %Focused training improved community health volunteers' knowledge on cervical cancer to 60.9% in the intervention arm compared to 13.4% in the control arm at end-line.

Kenyacancer du col de l'utéruspublié 2022Journal of cancer education : the official journal of the American Association for Cancer PubMeddocument de 3 observations

1,3 risk_ratioKnowing someone who had died due to cervical cancer was associated with an adjusted risk ratio of 1.30 for screening in Kenya.

Kenyacancer du col de l'utérusobservé 2022-2023publié 2025BMC public healthPubMeddocument de 8 observations

84 %Negative for intraepithelial lesion or malignancy accounted for 84.0% of cervical scrape samples.

Kenyacancer du col de l'utéruspublié 2025Acta cytologicaPubMeddocument de 7 observations

Cervical cancer is the leading cause of cancer-related deaths among women in sub-Saharan Africa.

Kenyacancer du col de l'utéruspublié 2025International journal of environmental research and public healthPubMeddocument de 3 observations

94,7 %Ninety-four point seven percent (94.7%) of respondents reported that cervical cancer screening was very useful in the prevention of cervical cancer.

Kenyacancer du col de l'utéruspublié 2016Journals & Books Hosting (International Knowledge Sharing Platform)OpenAlexdocument de 18 observations

0,67 prevalence_ratioThe prevalence ratio for cervical cancer screening in SAIA clinics compared to control clinics was 0.67 (95% CI 0.45–1.00) in the last quarter of the trial.

Kenyacancer du col de l'utéruspublié 2023Implementation science : ISeurope_pmcdocument de 5 observationsDOI 10.1186/s13012-023-01322-y

3,1 %Worldwide cervical cancer constitutes 3.1% of all cancer cases.

Kenyacancer du col de l'utéruspublié 2023BMC cancerPubMeddocument de 12 observations

42,2 %The 5-year relative survival for Stage I-II cervical cancer in low HDI registry areas was 42.2%.

Kenyacancer du col de l'utérusobservé 2005 to 2015publié 2020International journal of cancereurope_pmcdocument de 6 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.